FDA Issues EUA for Novavax’s Adjuvanted COVID-19 VaccineFDA/Regulatory, Marketing & Advertising, R&D, Therapeutics“Authorizing an additional COVID-19 vaccine expands the available vaccine options for the prevention of COVID-19, including the most severe outcomes that can occur such as hospitalization and death,” said FDA Commissioner Robert M. Califf, M.D. Read more July 14, 2022/by Administrator https://www.pharmalive.com/wp-content/uploads/2022/05/ReutersFDAlogo5-23-2022.webp 740 1200 Administrator https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Administrator2022-07-14 08:21:472022-07-14 08:25:01FDA Issues EUA for Novavax’s Adjuvanted COVID-19 Vaccine